v3.25.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenue:        
License and collaboration revenue     $ 10,000  
Total revenue $ 0 $ 0 10,000 $ 0
Operating expenses:        
Research and development 43,027 33,807 77,942 56,452
General and administrative 12,136 5,895 24,551 10,828
Total operating expenses 55,163 39,702 102,493 67,280
Loss from operations (55,163) (39,702) (92,493) (67,280)
Other income (expense), net:        
Fair value adjustments to convertible notes   (152)   (846)
Other income, net 2,960 1,877 6,512 2,349
Total other income (expense), net 2,960 1,725 6,512 1,503
Loss before income taxes (52,203) (37,977) (85,981) (65,777)
Income tax (provision) benefit (20)   185  
Net loss to common stockholders $ (52,223) $ (37,977) $ (85,796) $ (65,777)
Net loss per share attributable to common stockholders - basic (in dollars per share) $ (1.25) $ (24.23) $ (2.05) $ (42.15)
Net loss per share attributable to common stockholders - diluted (in dollars per share) $ (1.25) $ (24.23) $ (2.05) $ (42.15)
Weighted-average common stock outstanding - basic (in shares) 41,865,400 1,567,269 41,833,279 1,560,661
Weighted-average common stock outstanding - diluted (in shares) 41,865,400 1,567,269 41,833,279 1,560,661
Comprehensive loss:        
Net loss to common stockholders $ (52,223) $ (37,977) $ (85,796) $ (65,777)
Other comprehensive income (loss):        
Unrealized gain on investments 30   42  
Foreign currency translation adjustment (265) 30 (330) 67
Comprehensive loss $ (52,458) $ (37,947) $ (86,084) $ (65,710)